<ѻýҕl>VTE Risk After Joint Replacement: Does Anticoagulant Choice Matter?ѻýҕl> Large claims-based study provides some answers Dec 01, 2023
<ѻýҕl>Methotrexate Tied to Greater Risks for Older Patients With CKDѻýҕl> FDA should consider warning labels based on study results, researchers argue Nov 28, 2023
<ѻýҕl>Could Correcting Metabolic Dysfunction Treat Rheumatoid Arthritis?ѻýҕl> French researchers think they've identified a truly novel approach Nov 28, 2023
<ѻýҕl>Teen With Severe, Recalcitrant Dermatomyositis Seeks New Optionѻýҕl> Treatment-resistant juvenile dermatomyositis resolved by targeting elevated interferon-beta Nov 24, 2023
<ѻýҕl>Another Long-Acting Steroid Shot Impresses in Knee OAѻýҕl> Liposomal formulation OK for repeat dosing, phase III study indicates Nov 16, 2023
<ѻýҕl>Novel Gout Drug Aces Mid-Stage Testsѻýҕl> Mechanism different from currently available therapies Nov 16, 2023
<ѻýҕl>CAR T-Cell Approach to Autoimmune Disease Gains Tractionѻýҕl> Worries about vaccine responsiveness relieved; Big Pharma gets interested Nov 15, 2023
<ѻýҕl>Uh-Oh, Is a Robot Coming for Your Radiographic Analysis Job?ѻýҕl> Computer matches live expert in measuring joint space and erosions Nov 15, 2023
<ѻýҕl>Novel IL-17A Blocker Continues to Impress in PsAѻýҕl> More phase II data build case for izokibep Nov 14, 2023
<ѻýҕl>Some Gliflozin Side Effects Worse in Autoimmune Rheumatic Diseaseѻýҕl> Something to consider when prescribing SGLT-2 inhibitors Nov 14, 2023
<ѻýҕl>'Naked' Gene Therapy Promising for Osteoarthritisѻýҕl> Phase II results pave way for bigger and better trial Nov 13, 2023
<ѻýҕl>Long-Acting Steroid Gives 14 Weeks of Knee OA Reliefѻýҕl> Placebo-controlled trial gives novel product a tentative boost Nov 13, 2023
<ѻýҕl>Pregnant Patients With High Autoantibody Levels Need Fetal Heart Monitoringѻýҕl> Study should help target frequent testing to those most likely to benefit Nov 10, 2023
<ѻýҕl>B-Cell Depletion Helps Maintain Kidney Function in Lupus Nephritisѻýҕl> Secondary trial analysis boosts case for Gazyva Nov 10, 2023
<ѻýҕl>X-Rays Questioned for Diagnosing Early Rheumatoid Arthritisѻýҕl> Hardly any patients show abnormalities, so why do them? Nov 08, 2023
<ѻýҕl>JAK Inhibitor Safety Study Seen Altering Practice in the VAѻýҕl> Prescribing patterns for common RA drug shift in wake of landmark trial Nov 02, 2023
<ѻýҕl>Stelara Biosimilar OK'd With Interchangeabilityѻýҕl> But patent settlement may keep new product off market until 2025 Nov 01, 2023
<ѻýҕl>Sjogren's Without Dryness? Yes, It's a Thingѻýҕl> New study delves into unusual presentation Oct 30, 2023
<ѻýҕl>Novel Drug OK'd for Ulcerative Colitisѻýҕl> First agent to target p19 subunit of IL-23 Oct 27, 2023
<ѻýҕl>Major Source of Lupus Morbidity More Common in Certain Racial-Ethnic Groupsѻýҕl> Good news is that it's not common overall Oct 25, 2023
<ѻýҕl>Want to Reduce Knee OA Risk? Weight Work May Helpѻýҕl> History of strength training tied to reduced incidence later in life Oct 23, 2023
<ѻýҕl>CDC: Arthritis Is Massive Public Health Problemѻýҕl> One in five adults, nearly half of seniors diagnosed with joint diseases Oct 13, 2023
<ѻýҕl>A Price Jump From Pennies to $20/Pill for the Same Drugѻýҕl> Drug pricing should be subject to stricter regulation Oct 12, 2023
<ѻýҕl>Surprising Link Between Weight Gain and RA Activityѻýҕl> Hint: it's not the worsening you probably expected Oct 09, 2023
<ѻýҕl>Bimekizumab Data in axSpA Look Good Through 1 Yearѻýҕl> U.S. approval status for IL-17A/F inhibitor still in limbo Oct 05, 2023
<ѻýҕl>Everything (Maybe) You Wanted to Know About Sarilumab for PMRѻýҕl> Published details may raise questions about FDA's approval Oct 04, 2023
<ѻýҕl>Actemra Biosimilar Approvedѻýҕl> But Biogen product doesn't get all the original's indications Oct 03, 2023
<ѻýҕl>Could This Neuroleptic Ward Off RA?ѻýҕl> Retrospective data suggest a preventive effect for old-line antipsychotic drug Sep 13, 2023
<ѻýҕl>Here's Another Racial-Ethnic Disparity in Back Pain Careѻýҕl> Nonwhite patients who overuse opioids are given nonpharmacologic alternatives less often Sep 12, 2023
<ѻýҕl>Rheum Patients on HCQ: Stick With It or Face Heart Consequencesѻýҕl> Population-based study links adherence with risk for cardiovascular events Sep 11, 2023
<ѻýҕl>Run This Test Before Diagnosing Fibromyalgiaѻýҕl> Study suggests 10% of cases may have easily treatable cause Sep 06, 2023
<ѻýҕl>What Changed FDA's Mind About Ilaris for Gout?ѻýҕl> Approval comes after previous rejections Sep 05, 2023
<ѻýҕl>Joint Replacement Outcomes a Bit Better With Patient Reports Post-Surgeryѻýҕl> Not a huge benefit, study finds, but could be a step toward more consistent follow-up care Sep 01, 2023
<ѻýҕl>U.S. Unveils First 10 Drugs for Medicare Price Negotiationsѻýҕl> Treatments for heart failure, Crohn's disease, and diabetes make the list Aug 29, 2023
<ѻýҕl>Case Grows for SGLT2 Inhibitors as Gout Treatmentѻýҕl> Large cohort study shows expansive benefits Aug 28, 2023
<ѻýҕl>Blood Test Could Ease Diagnosis of Kids' Inflammatory Conditionsѻýҕl> Just one biomarker distinguished Kawasaki disease from others with similar clinical features Aug 25, 2023
<ѻýҕl>Still No Easy Way to Take RA Patients Off Anti-TNF Drugsѻýҕl> Randomized trial tests a withdrawal strategy, with mixed results Aug 23, 2023
<ѻýҕl>Tool Predicts PsA Progression From Psoriasis, No Fancy Biomarkers Neededѻýҕl> New model estimates risk from routine clinical parameters Aug 09, 2023
<ѻýҕl>Certain Medications Tied to Post-COVID Pulmonary Fibrosisѻýҕl> Rituximab and chemotherapy singled out in U.S. dataset Aug 08, 2023
<ѻýҕl>Steroid Tapering Called Safe in Older RA Patientsѻýҕl> Trial follow-up demonstrates feasibility, though not without some risk Aug 07, 2023